UTMB OAIC Clinical Research Resource Core 2 (CRRC2)
UTMB OAIC 临床研究资源核心 2 (CRRC2)
基本信息
- 批准号:10670188
- 负责人:
- 金额:$ 18.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-06-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAdipose tissueAgingAmericanAspirinBehavior TherapyBehavioralBiologyBiometryBiopsyBody CompositionCapsicumCaringClinicClinical ResearchClinical TrialsClinical and Translational Science AwardsCommunitiesData Management ResourcesDevelopmentDietary InterventionElderlyElectronic Health RecordEmerging TechnologiesEnsureEventExercise TestFailureGoalsHealthHealth Insurance Portability and Accountability ActHealthcareHispanicHospitalizationHospitalsIndividualInfrastructureInterventionLaboratoriesLaboratory ResearchLeadershipLong-Term Care for ElderlyMeasurementMedicalMetabolismMethodologyMethodsMolecularMonitorMulti-Institutional Clinical TrialMuscleNutritionalNutritional statusOutcomes ResearchParticipantPathway interactionsPatient AdmissionPatient-Focused OutcomesPatientsPhysical FunctionPhysical activityPilot ProjectsPoliciesPopulationPopulation HeterogeneityProceduresProductivityProtocols documentationRecoveryRecovery of FunctionRegulationResearchResearch PersonnelResearch SupportResearch TrainingResourcesRisk ReductionRunningSafetyStandardizationTeacher Professional DevelopmentTechniquesTechnologyTestingTexasTrainingTransducersTranslatingTranslational ResearchTranslationsUniversitiesUpdateacute carecareer developmentclinical investigationeducation researcheducation resourcesethnic minority populationexercise interventionexercise trainingfunctional outcomeshuman subjecthuman subject protectionimprovedinnovationinvestigator trainingloss of functionnovelnutritionpatient orientedpatient safetyphysically handicappedracial minority populationrecruitresearch studyretention ratesatisfactionscreeningstandardize measuretimelinewardworking group
项目摘要
PROJECT SUMMARY/ABSTRACT (CRRC2)
The UTMB OAIC Clinical Research Resource Core (CRRC2) is the primary resource to support clinical
research, including subject recruitment, tracking and retention activities, and investigators’ training. In the new
cycle, the core will support research studies on the mechanisms underlying function loss and recovery;
development and testing of novel treatments; trajectories of physical function and disability in community-
dwelling and hospitalized older adults; and pragmatic, patient-centered studies on recovery from illness. All
CRRC2 activities will support the broader OAIC theme: Translate pathways of function loss and gain into
interventions to improve functional recovery in diverse geriatric populations.
The Specific Aims of the CRRC2 are:
1. Support clinical research relevant to the OAIC theme.
2. Coordinate training in recruitment, retention, and study procedures.
3. Develop novel methods to improve clinical study recruitment, retention and diversity.
The CRRC2 has supported over the current cycle translational research in healthy older adults and geriatric
patients, including 31 OAIC projects and 43 external projects. Core expertise in muscle biology, metabolism,
nutrition, exercise, and behavioral interventions has been instrumental in developing the infrastructure to
support translation of basic discoveries in geriatric populations, developing the ACE Unit Functional
Laboratory, and participating in large multisite clinical trials.
Going forward the CRRC2 will continue to recruit, track and retain diverse older adults for supported projects,
including OAIC Network multisite clinical trials; provide standardized health screenings, physical exams,
functional, nutritional and body composition assessments, exercise testing and training, and muscle and
adipose tissue biopsies; monitor compliance and safety; train investigators; support use of technology in
clinical trials; improve methodologies to enhance retention and intervention fidelity; and develop best practices
to recruit diverse Hispanic participants in clinical studies. The CRRC2 will continue to enhance the OAIC
clinical research quality, efficiency, productivity, and provide developmental opportunities for scholars and
other investigators.
项目摘要/摘要(CRRC2)
UTMB OAIC临床研究资源核心(CRRC2)是支持临床的主要资源
研究,包括受试者招募、跟踪和保留活动以及调查人员培训。在新的
在周期中,核心将支持对功能丧失和恢复的潜在机制的研究;
开发和测试新的治疗方法;社区中身体功能和残疾的轨迹-
居住和住院的老年人;以病人为中心的关于疾病康复的务实研究。全
CRRC2活动将支持更广泛的OAIC主题:将功能丧失和获得的途径转化为
促进不同老年人群功能恢复的干预措施。
CRRC2的具体目标是:
1.支持与OAIC主题相关的临床研究。
2.协调招聘、保留和学习程序方面的培训。
3.开发新的方法来提高临床研究的招募、保留和多样性。
CRRC2在当前周期内支持了对健康老年人和老年人的翻译研究
患者,包括31个OAIC项目和43个外部项目。肌肉生物学、新陈代谢、
营养、锻炼和行为干预在发展基础设施方面发挥了重要作用
支持老年人群基本发现的翻译,开发ACE单位的功能
实验室,并参与大型多点临床试验。
展望未来,CRRC2将继续为支持的项目招募、跟踪和留住不同的老年人,
包括OAIC网络多点临床试验;提供标准化的健康筛查、体检、
功能、营养和身体成分评估、运动测试和训练,以及肌肉和
脂肪组织活组织检查;监测遵从性和安全性;培训调查人员;支持在
临床试验;改进方法以提高保留率和干预保真度;开发最佳实践
在临床研究中招募不同的西班牙裔参与者。CRRC2将继续加强OAIC
临床研究的质量、效率、生产力,并为学者和
其他调查人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elena Volpi其他文献
Elena Volpi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elena Volpi', 18)}}的其他基金
Closeout Bridging Administrative Supplement to R01AG049611
R01AG049611 的清仓桥接管理补充
- 批准号:
10281452 - 财政年份:2016
- 资助金额:
$ 18.61万 - 项目类别:
Identifying therapeutic targets of accelerated sarcopenia
确定加速肌少症的治疗靶点
- 批准号:
9056065 - 财政年份:2016
- 资助金额:
$ 18.61万 - 项目类别:
NUTRITION & EXERCISE TO IMPROVE PROTEIN METABOLISM & PREVENT SARCOPENIA IN AGING
营养
- 批准号:
7952172 - 财政年份:2009
- 资助金额:
$ 18.61万 - 项目类别:
CLINICAL TRIAL: INSULIN AND SARCOPENIA IN THE ELDERLY (CYCLE NO, 2)
临床试验:老年人的胰岛素和肌肉减少症(第 2 周期)
- 批准号:
7952154 - 财政年份:2009
- 资助金额:
$ 18.61万 - 项目类别:
CLINICAL TRIAL: NUTRITIONAL INTERVENTIONS FOR MAXIMAL MUSCLE GAIN IN MIDDLE-AGED
临床试验:中年人最大肌肉增长的营养干预
- 批准号:
7952163 - 财政年份:2009
- 资助金额:
$ 18.61万 - 项目类别:
Nutrition & Exercise to Improve Protein Metabolism & Prevent Sarcopenia in Aging
营养
- 批准号:
8073013 - 财政年份:2008
- 资助金额:
$ 18.61万 - 项目类别:
CLINICAL TRIAL: NUTRITIONAL INTERVENTIONS FOR MAXIMAL MUSCLE GAIN IN MIDDLE-AGED
临床试验:中年人最大肌肉增长的营养干预
- 批准号:
7719200 - 财政年份:2008
- 资助金额:
$ 18.61万 - 项目类别:
Nutrition & Exercise to Improve Protein Metabolism & Prevent Sarcopenia in Aging
营养
- 批准号:
8141802 - 财政年份:2008
- 资助金额:
$ 18.61万 - 项目类别:
Nutrition & Exercise to Improve Protein Metabolism & Prevent Sarcopenia in Aging
营养
- 批准号:
8277275 - 财政年份:2008
- 资助金额:
$ 18.61万 - 项目类别:
CLINICAL TRIAL: INSULIN AND SARCOPENIA IN THE ELDERLY (CYCLE NO, 2)
临床试验:老年人的胰岛素和肌肉减少症(第 2 周期)
- 批准号:
7719189 - 财政年份:2008
- 资助金额:
$ 18.61万 - 项目类别:
相似海外基金
Role of Histone Deacetylase 9 (HDAC9) in adipose tissue aging: mitochondrial function, oxidative stress and senescence
组蛋白脱乙酰酶 9 (HDAC9) 在脂肪组织衰老中的作用:线粒体功能、氧化应激和衰老
- 批准号:
10707000 - 财政年份:2022
- 资助金额:
$ 18.61万 - 项目类别:
Effects of aging and exercise training on intermuscular adipose tissue (IMAT) in MoTrPAC
衰老和运动训练对 MoTrPAC 肌间脂肪组织 (IMAT) 的影响
- 批准号:
10467912 - 财政年份:2022
- 资助金额:
$ 18.61万 - 项目类别:
Marrow Adipose Tissue as a Novel Regulator of Systemic Metabolism and Inflammation During Aging.
骨髓脂肪组织作为衰老过程中全身代谢和炎症的新型调节器。
- 批准号:
10349939 - 财政年份:2022
- 资助金额:
$ 18.61万 - 项目类别:
Effects of aging and exercise training on intermuscular adipose tissue (IMAT) in MoTrPAC
衰老和运动训练对 MoTrPAC 肌间脂肪组织 (IMAT) 的影响
- 批准号:
10703366 - 财政年份:2022
- 资助金额:
$ 18.61万 - 项目类别:
Marrow Adipose Tissue as a Novel Regulator of Systemic Metabolism and Inflammation During Aging.
骨髓脂肪组织作为衰老过程中全身代谢和炎症的新型调节器。
- 批准号:
10689661 - 财政年份:2022
- 资助金额:
$ 18.61万 - 项目类别:
Syndecan-4 as a molecular link between adipose tissue and aging
Syndecan-4 作为脂肪组织与衰老之间的分子联系
- 批准号:
10232057 - 财政年份:2020
- 资助金额:
$ 18.61万 - 项目类别:
Syndecan-4 as a molecular link between adipose tissue and aging
Syndecan-4 作为脂肪组织与衰老之间的分子联系
- 批准号:
9894151 - 财政年份:2020
- 资助金额:
$ 18.61万 - 项目类别:
Pathophysiological functions of a multifunctional molecule, myoferlin, in adipose tissue and its involvement in individual aging
多功能分子肌铁蛋白在脂肪组织中的病理生理功能及其与个体衰老的关系
- 批准号:
20K22873 - 财政年份:2020
- 资助金额:
$ 18.61万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Investigating the role of adipose tissue in mobility and aging (SOMMA-AT)
研究脂肪组织在活动能力和衰老中的作用 (SOMMA-AT)
- 批准号:
10083347 - 财政年份:2020
- 资助金额:
$ 18.61万 - 项目类别: